Press releases & Media

Press releases

• Groves Medical Group starts offering Stockholm3 in the UK
  February 1, 2023
• Clinical study validates that Stockholm3 provides significantly higher clinical benefit than European prostate cancer risk calculator
  January 12, 2023
• A3P Biomedical appoints Andreas Hoel as new VP of Marketing & Sales
  November 1, 2022

More press releases

A3P in media

• Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
  May 6, 2022
• Finally time for public screening of prostate cancer? (In Swedish)
  November 22, 2021
• Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
  October 6, 2021

More articles